文献速递急性肾损伤

内皮源性miR-17∼92通过促进血管生成保护肾缺血再灌注损伤

Endothelial-Derived miR-17∼92 Promotes Angiogenesis to Protect against Renal Ischemia-Reperfusion Injury.
PubMed 文献 · J Am Soc Nephrol · 2021-01-29

该研究在小鼠肾缺血再灌注损伤(IRI)模型中探究内皮特异性miR-17∼92簇的作用。内皮特异性敲除miR-17∼92加重肾小管损伤、降低肾血流、促进微血管稀疏、增加氧化应激和巨噬细胞浸润,而miR-18a和miR-19b模拟物可减轻损伤。结果表明内皮源性miR-17∼92通过调控血管生成通路刺激损伤肾血管的修复反应。

要点

  • 内皮特异性敲除miR-17∼92加重小鼠肾IRI,提示该簇具有保护作用。
  • miR-17∼92缺失导致肾血流下降、微血管稀疏和氧化应激增加。
  • miR-18a和miR-19b模拟物可减轻肾IRI,TSP1是其靶点。

核心结论

  • 内皮源性miR-17∼92通过调控血管生成通路刺激损伤肾血管的修复反应,从而保护肾IRI。

研究设计与样本

  • 利用磁珠偶联抗体从小鼠中富集肾内皮细胞,构建内皮特异性miR-17∼92敲除(miR-17∼92endo-/-)小鼠并给予肾IRI。
  • 通过血清生化、组织学、磁共振成像(MRI)和激光多普勒成像监测AKI及肾血流,并评估miRNA模拟物治疗效力。

主要发现

  • 肾IRI后肾内皮细胞中miR-17、miR-18a、miR-20a、miR-19b和pri-miR-17∼92呈动态调控。
  • miR-17∼92endo-/-在雄性和雌性小鼠中均加重肾IRI,促进肾小管损伤、降低肾血流、促进微血管稀疏、增加肾氧化应激和巨噬细胞浸润。
  • miR-17∼92endo-/-肾IRI后内皮高表达强抗血管生成因子TSP1,且TSP1是miR-18a和miR-19a/b的靶点。
  • miR-18a和miR-19b模拟物可减轻肾IRI。

临床怎么用

  • 靶向miR-18a和miR-19b模拟物可能成为减轻肾缺血再灌注损伤的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Damage to the renal microvasculature is a hallmark of renal ischemia-reperfusion injury (IRI)-mediated AKI. The miR-17∼92 miRNA cluster (encoding miR-17, -18a, -19a, -20a, -19b-1, and -92a-1) regulates angiogenesis in multiple settings, but no definitive role in renal endothelium during AKI pathogenesis has been established. METHODS: Antibodies bound to magnetic beads were utilized to selectively enrich for renal endothelial cells from mice. Endothelial-specific miR-17∼92 knockout (miR-17∼92endo-/- ) mice were generated and given renal IRI. Mice were monitored for the development of AKI using serum chemistries and histology and for renal blood flow using magnetic resonance imaging (MRI) and laser Doppler imaging. Mice were treated with miRNA mimics during renal IRI, and therapeutic efficacies were evaluated. RESULTS: miR-17, -18a, -20a, -19b, and pri-miR-17∼92 are dynamically regulated in renal endothelial cells after renal IRI. miR-17∼92endo-/- exacerbates renal IRI in male and female mice. Specifically, miR-17∼92endo-/- promotes renal tubular injury, reduces renal blood flow, promotes microvascular rarefaction, increases renal oxidative stress, and promotes macrophage infiltration to injured kidneys. The potent antiangiogenic factor thrombospondin 1 (TSP1) is highly expressed in renal endothelium in miR-17∼92endo-/- after renal IRI and is a target of miR-18a and miR-19a/b. miR-17∼92 is critical in the angiogenic response after renal IRI, which treatment with miR-18a and miR-19b mimics can mitigate. CONCLUSIONS: These data suggest that endothelial-derived miR-17∼92 stimulates a reparative response in damaged renal vasculature during renal IRI by regulating angiogenic pathways.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Chiba T, Cerqueira DM, Li Y, et al. Endothelial-Derived miR-17∼92 Promotes Angiogenesis to Protect against Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2021. PMID: 33514560. doi:10.1681/ASN.2020050717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。